Development, Characterization, and in vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer.
Saved in:
| Title: | Development, Characterization, and in vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Diorio AM; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Jamaica, USA., Daram A; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Jamaica, USA., Sriram N; Catalent Pharma Solutions, Somerset, USA., Lund T; Catalent Pharma Solutions, Somerset, USA., Watts AB; Catalent Pharma Solutions, Somerset, USA., Kunda NK; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Jamaica, USA. kundan@stjohns.edu. |
| Source: | AAPS PharmSciTech [AAPS PharmSciTech] 2025 Jul 30; Vol. 26 (7), pp. 204. Date of Electronic Publication: 2025 Jul 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1530-9932 |
|---|---|
| DOI: | 10.1208/s12249-025-03200-w |
